PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 153-156
10.1002/hon.3163_102